Rosacea Medications - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Rosacea Medications Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Rosacea Medications Market Restraints
Table 3. Rosacea Medications Market Trends
Table 4. Rosacea Medications Industry Policy
Table 5. Global Rosacea Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Rosacea Medications Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Rosacea Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Rosacea Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Rosacea Medications Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Rosacea Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Rosacea Medications Mergers & Acquisitions, Expansion Plans
Table 12. Global Rosacea Medications Manufacturers Product Type
Table 13. Head Office and Rosacea Medications Production Site of Key Manufacturer
Table 14. Rosacea Medications Capacity of Major Manufacturers and Future Plan
Table 15. China Rosacea Medications Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Rosacea Medications Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Rosacea Medications Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Rosacea Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Rosacea Medications Production by Region, 2018-2023, (K Units)
Table 20. Global Rosacea Medications Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Rosacea Medications Upstream (Raw Materials)
Table 22. Global Rosacea Medications Typical Customers
Table 23. Rosacea Medications Typical Distributors
Table 24. By Type, Global Rosacea Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Rosacea Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Rosacea Medications Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Rosacea Medications Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Rosacea Medications Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Rosacea Medications Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Rosacea Medications Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Rosacea Medications Sales Quantity Market Share, 2018-2029
Table 34. Lupin Ltd Company Information, Head Office, Market Area, and Industry Position
Table 35. Lupin Ltd Rosacea Medications Models, Specifications, and Application
Table 36. Lupin Ltd Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Lupin Ltd Company Profile and Main Business
Table 38. Lupin Ltd Recent Developments
Table 39. Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area, and Industry Position
Table 40. Dr. Reddy's Laboratories Ltd Rosacea Medications Models, Specifications, and Application
Table 41. Dr. Reddy's Laboratories Ltd Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Dr. Reddy's Laboratories Ltd Company Profile and Main Business
Table 43. Dr. Reddy's Laboratories Ltd Recent Developments
Table 44. VIATRIS (Mylan N.V.) Company Information, Head Office, Market Area, and Industry Position
Table 45. VIATRIS (Mylan N.V.) Rosacea Medications Models, Specifications, and Application
Table 46. VIATRIS (Mylan N.V.) Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. VIATRIS (Mylan N.V.) Company Profile and Main Business
Table 48. VIATRIS (Mylan N.V.) Recent Developments
Table 49. Ajanta Pharma Ltd Company Information, Head Office, Market Area, and Industry Position
Table 50. Ajanta Pharma Ltd Rosacea Medications Models, Specifications, and Application
Table 51. Ajanta Pharma Ltd Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Ajanta Pharma Ltd Company Profile and Main Business
Table 53. Ajanta Pharma Ltd Recent Developments
Table 54. Cipla Ltd Company Information, Head Office, Market Area, and Industry Position
Table 55. Cipla Ltd Rosacea Medications Models, Specifications, and Application
Table 56. Cipla Ltd Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Cipla Ltd Company Profile and Main Business
Table 58. Cipla Ltd Recent Developments
Table 59. Gary Pharmaceuticals P Limited Company Information, Head Office, Market Area, and Industry Position
Table 60. Gary Pharmaceuticals P Limited Rosacea Medications Models, Specifications, and Application
Table 61. Gary Pharmaceuticals P Limited Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Gary Pharmaceuticals P Limited Company Profile and Main Business
Table 63. Gary Pharmaceuticals P Limited Recent Developments
Table 64. Glenmark Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 65. Glenmark Pharmaceuticals Rosacea Medications Models, Specifications, and Application
Table 66. Glenmark Pharmaceuticals Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Glenmark Pharmaceuticals Company Profile and Main Business
Table 68. Glenmark Pharmaceuticals Recent Developments
Table 69. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 70. Teva Pharmaceutical Industries Ltd. Rosacea Medications Models, Specifications, and Application
Table 71. Teva Pharmaceutical Industries Ltd. Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 73. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 74. Mission Pharmacal Company Information, Head Office, Market Area, and Industry Position
Table 75. Mission Pharmacal Rosacea Medications Models, Specifications, and Application
Table 76. Mission Pharmacal Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Mission Pharmacal Company Profile and Main Business
Table 78. Mission Pharmacal Recent Developments
Table 79. Sanofi SA Company Information, Head Office, Market Area, and Industry Position
Table 80. Sanofi SA Rosacea Medications Models, Specifications, and Application
Table 81. Sanofi SA Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Sanofi SA Company Profile and Main Business
Table 83. Sanofi SA Recent Developments
Table 84. VYNE Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 85. VYNE Therapeutics Rosacea Medications Models, Specifications, and Application
Table 86. VYNE Therapeutics Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. VYNE Therapeutics Company Profile and Main Business
Table 88. VYNE Therapeutics Recent Developments
Table 89. Galderma Company Information, Head Office, Market Area, and Industry Position
Table 90. Galderma Rosacea Medications Models, Specifications, and Application
Table 91. Galderma Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Galderma Company Profile and Main Business
Table 93. Galderma Recent Developments
Table 94. Bayer AG Company Information, Head Office, Market Area, and Industry Position
Table 95. Bayer AG Rosacea Medications Models, Specifications, and Application
Table 96. Bayer AG Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Bayer AG Company Profile and Main Business
Table 98. Bayer AG Recent Developments
Table 99. Bausch Health Companies Inc. Company Information, Head Office, Market Area, and Industry Position
Table 100. Bausch Health Companies Inc. Rosacea Medications Models, Specifications, and Application
Table 101. Bausch Health Companies Inc. Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Bausch Health Companies Inc. Company Profile and Main Business
Table 103. Bausch Health Companies Inc. Recent Developments
Table 104. Hovione Company Information, Head Office, Market Area, and Industry Position
Table 105. Hovione Rosacea Medications Models, Specifications, and Application
Table 106. Hovione Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Hovione Company Profile and Main Business
Table 108. Hovione Recent Developments
Table 109. PruGen Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 110. PruGen Pharmaceuticals Rosacea Medications Models, Specifications, and Application
Table 111. PruGen Pharmaceuticals Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. PruGen Pharmaceuticals Company Profile and Main Business
Table 113. PruGen Pharmaceuticals Recent Developments
Table 114. AbbVie, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 115. AbbVie, Inc. Rosacea Medications Models, Specifications, and Application
Table 116. AbbVie, Inc. Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. AbbVie, Inc. Company Profile and Main Business
Table 118. AbbVie, Inc. Recent Developments
Table 119. Eckson Labs Company Information, Head Office, Market Area, and Industry Position
Table 120. Eckson Labs Rosacea Medications Models, Specifications, and Application
Table 121. Eckson Labs Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Eckson Labs Company Profile and Main Business
Table 123. Eckson Labs Recent Developments
Table 124. Sandoz Spa Company Information, Head Office, Market Area, and Industry Position
Table 125. Sandoz Spa Rosacea Medications Models, Specifications, and Application
Table 126. Sandoz Spa Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Sandoz Spa Company Profile and Main Business
Table 128. Sandoz Spa Recent Developments
Table 129. Abigail Care Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 130. Abigail Care Pharmaceutical Rosacea Medications Models, Specifications, and Application
Table 131. Abigail Care Pharmaceutical Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Abigail Care Pharmaceutical Company Profile and Main Business
Table 133. Abigail Care Pharmaceutical Recent Developments
Table 134. Pfizer Inc. Rosacea Medications Company Information, Head Office, Market Area, and Industry Position
Table 135. Pfizer Inc. Rosacea Medications Models, Specifications, and Application
Table 136. Pfizer Inc. Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 137. Pfizer Inc. Company Profile and Main Business
Table 138. Pfizer Inc. Recent Developments
Table 139. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Information, Head Office, Market Area, and Industry Position
Table 140. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Rosacea Medications Models, Specifications, and Application
Table 141. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Rosacea Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 142. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Profile and Main Business
Table 143. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments
List of Figures
Figure 1. Rosacea Medications Picture
Figure 2. Global Rosacea Medications Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Rosacea Medications Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Rosacea Medications Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Rosacea Medications Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Rosacea Medications Sales Quantity (K Units) & (2018-2029)
Figure 7. China Rosacea Medications Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Rosacea Medications Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Rosacea Medications Market Share of Global, 2018-2029
Figure 10. Global Rosacea Medications Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Rosacea Medications Key Participants, Market Share, 2022
Figure 12. Global Rosacea Medications Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Rosacea Medications Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Rosacea Medications Production Market Share & Forecast by Region, 2018-2029
Figure 15. Rosacea Medications Industry Chain
Figure 16. Rosacea Medications Procurement Model
Figure 17. Rosacea Medications Sales Model
Figure 18. Rosacea Medications Sales Channels, Direct Sales, and Distribution
Figure 19. Antibiotic
Figure 20. Immunosuppressants
Figure 21. Corticosteroids
Figure 22. Others
Figure 23. By Type, Global Rosacea Medications Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Rosacea Medications Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Rosacea Medications Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Rosacea Medications Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Hospital
Figure 29. Clinic
Figure 30. Others
Figure 31. By Application, Global Rosacea Medications Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Rosacea Medications Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Rosacea Medications Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Rosacea Medications Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Rosacea Medications Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Rosacea Medications Sales Quantity Market Share, 2018-2029
Figure 38. North America Rosacea Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Rosacea Medications Consumption Value Market Share, 2022
Figure 40. Europe Rosacea Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Rosacea Medications Consumption Value Market Share, 2022
Figure 42. Asia Pacific Rosacea Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Rosacea Medications Consumption Value Market Share, 2022
Figure 44. South America Rosacea Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Rosacea Medications Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Rosacea Medications Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Rosacea Medications Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Rosacea Medications Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets